[
  {
    "ts": null,
    "headline": "Enterprise Software, Health Care Stocks Miss Out on Broader Rally",
    "summary": "Most of the market was feasting on another helping of Thanksgiving week gains on Wednesday, but enterprise software and health care stocks were missing out on the celebration.  Workday was the biggest laggard in the S&P 500 and among the fewer than 90 stocks in the index that were trading lower on Wednesday.  Salesforce, another major player in enterprise software, reports quarterly results a week from today.",
    "url": "https://finnhub.io/api/news?id=d157cb0593d1ef050aeb95ae1969cc658901c7527533459d83c8c47a559a7c8d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764184696,
      "headline": "Enterprise Software, Health Care Stocks Miss Out on Broader Rally",
      "id": 137619078,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Most of the market was feasting on another helping of Thanksgiving week gains on Wednesday, but enterprise software and health care stocks were missing out on the celebration.  Workday was the biggest laggard in the S&P 500 and among the fewer than 90 stocks in the index that were trading lower on Wednesday.  Salesforce, another major player in enterprise software, reports quarterly results a week from today.",
      "url": "https://finnhub.io/api/news?id=d157cb0593d1ef050aeb95ae1969cc658901c7527533459d83c8c47a559a7c8d"
    }
  },
  {
    "ts": null,
    "headline": "CMS Slashes Prices Of 15 Major Drugs - Here's Why Pharma Valuations Won't Suffer",
    "summary": "Discover how new U.S. Medicare drug price cuts impact major pharma stocks like Novo Nordisk and why sector resilience supports a strong outlook. Click for more.",
    "url": "https://finnhub.io/api/news?id=1f6a4babd9bee8ff46ea9bfd57aa2d2c9e4fb232cd4ea10363ae33b37483d4b4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764176336,
      "headline": "CMS Slashes Prices Of 15 Major Drugs - Here's Why Pharma Valuations Won't Suffer",
      "id": 137615519,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1407294139/image_1407294139.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Discover how new U.S. Medicare drug price cuts impact major pharma stocks like Novo Nordisk and why sector resilience supports a strong outlook. Click for more.",
      "url": "https://finnhub.io/api/news?id=1f6a4babd9bee8ff46ea9bfd57aa2d2c9e4fb232cd4ea10363ae33b37483d4b4"
    }
  },
  {
    "ts": null,
    "headline": "CURE: Analysts Strike A Cautious Tone Heading Into 2026",
    "summary": "Discover why the Direxion Healthcare Bull 3X ETF is outperforming in 2025. Learn about key risks, returns, and buy ratings.",
    "url": "https://finnhub.io/api/news?id=a5ef5754831c30f25c83c66be5e038c5194b41554790fb800b0ad9b7a81a6a4b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764174517,
      "headline": "CURE: Analysts Strike A Cautious Tone Heading Into 2026",
      "id": 137615429,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2009808479/image_2009808479.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Discover why the Direxion Healthcare Bull 3X ETF is outperforming in 2025. Learn about key risks, returns, and buy ratings.",
      "url": "https://finnhub.io/api/news?id=a5ef5754831c30f25c83c66be5e038c5194b41554790fb800b0ad9b7a81a6a4b"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights",
    "summary": "ABBV's surging immunology sales and smoother LOE path stand out as both drugmakers face a pivotal 2026.",
    "url": "https://finnhub.io/api/news?id=6ac81ded30baa5da034478881631ffce1a918e07dea7f3e46eead3cfc0a99ab1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764171720,
      "headline": "AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights",
      "id": 137614448,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "ABBV's surging immunology sales and smoother LOE path stand out as both drugmakers face a pivotal 2026.",
      "url": "https://finnhub.io/api/news?id=6ac81ded30baa5da034478881631ffce1a918e07dea7f3e46eead3cfc0a99ab1"
    }
  },
  {
    "ts": null,
    "headline": "Is AbbVie Stock Outperforming the Nasdaq?",
    "summary": "AbbVie has outperformed the Nasdaq over the past year, and analysts are moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=f2c3871d54c6ba30ea725299e857b304f9654a1c927e5e70cfbf4fbe2d90f05f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764169345,
      "headline": "Is AbbVie Stock Outperforming the Nasdaq?",
      "id": 137614478,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie has outperformed the Nasdaq over the past year, and analysts are moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=f2c3871d54c6ba30ea725299e857b304f9654a1c927e5e70cfbf4fbe2d90f05f"
    }
  },
  {
    "ts": null,
    "headline": "Centers for Medicare & Medicaid Services Unveils $12 Billion Net Savings From Reduction in Drug Prices",
    "summary": "The Centers for Medicare & Medicaid Services said Tuesday it expects to achieve net savings of 44%,",
    "url": "https://finnhub.io/api/news?id=ed453e3d99118aaec5caa763ba61f4f17ea380d03972a2844140b4163ff336ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764151222,
      "headline": "Centers for Medicare & Medicaid Services Unveils $12 Billion Net Savings From Reduction in Drug Prices",
      "id": 137611270,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The Centers for Medicare & Medicaid Services said Tuesday it expects to achieve net savings of 44%,",
      "url": "https://finnhub.io/api/news?id=ed453e3d99118aaec5caa763ba61f4f17ea380d03972a2844140b4163ff336ee"
    }
  }
]